Posts Tagged ‘Botox’

FDA Approves Botox for Chronic Migraine Headaches

Saturday, October 16th, 2010

On Friday, the Food and Drug Administration gave clearance for Botox to be used as a preventive treatment for chronic migraine headaches. The approval means that therapeutic treatments with Botox could begin to surpass the number of cosmetic treatments.

People suffering from chronic migraines regularly experience an intense throbbing pain in one area of the head, a condition that’s often very debilitating.  To help prevent migraines, Botox injections are administered every 12 weeks around the head and neck. The injections are only intended for treating severe headaches that occur more than 14 days in one month. Neurologists believe Botox migraine treatments may work by disrupting the transmission of pain signals to the nerve endings.

Some analysts say Botox sales will dramatically increase, while others remain unconvinced. According to an article in the New York Times, some argue that “minimal” effectiveness and high cost will prevent Botox from being embraced by most doctors and patients.

Read the FDA press release

Mark Mandell Brown Warns Against Botox Breast Lift

Wednesday, October 14th, 2009

botox_breastliftDoctor Mandell-Brown recently appeared on Local 12 to answer the question “What is a Botox Breast lift?”  You can see a video of this appearance on our media page.
The report explains that although the breast lift is common, and Botox is practical and effective, the so-called Botox Breast Lift is not a cost effective cosmetic treatment people should consider.

The most common theory behind this procedure posits that Botox injections can relax muscles and affect a woman’s posture in such a way that simulates lifting of the breasts.  Dr. Mandell Brown answers the question conclusively:

“Rather than spend four or five or ten thousand dollars on a breast lift, lets do $200-$300 of botox. Are we just throwing away the 300 dollars then? Yes. Is there any research to support that this would be even remotely effective? No. In reality, the tissue’s too heavy for that to happen.”

Click here to read more about breast lift surgery in Cincinnati.

The "Liquid Face Lift" Featured in Harper’s Bazaar

Friday, September 4th, 2009

harper'sThe so-called liquid facelift has once again been featured by a national media outlet.  Harper’s Baazar recently posted an excellent article that outlines the pros and cons of all the latest wrinkle fillers.  The Best Beauty section of the September issue includes before and after pictures and a discussion of professional techniques for administering injectables.

The idea of a liquid facelift isn’t exactly a “touch up” here and there, but a relatively extensive  series of injections intended to achieve results similar to a surgical facelift, yet the results are “typically more subtle than surgery.”  According to the authors, you can expect to pay at least $3,000 for a full liquid facelift.  A Florida dermatologist by the name of Dr. Fredric Brandt explains, “I resuspend the face with Botox, lifting up the brows, neck, jawline, and tip of the nose and then fill in and replace volume around the eyes and cheeks.”  Some of the products and procedures discussed in the aforementioned article include Juvederm, Restylane, Perlane, Botox, Sculptra, and fat transfer.

The liquid facelift has also been featured on The Doctors (NBC), Rachel Ray Show, New Beauty Magazine, Dr. 90210, FOX News, Cosmetic Surgery Times, and more exposure is said to be in the works.

For more information, you might want to view www.liquidfacelift.com/ or contact us at the office of Dr. Mandell-Brown.

Seeking a New Career? Cosmetic Enhancements Can’t Hurt

Wednesday, August 12th, 2009

Cincinatti BotoxAlthough the economic news this week is looking optimistic, the job market is still a rough environment to navigate.  We’ve had more than one patient comment about it and share suspicions about age, or appearance, negatively affecting job prospects.  My neighbor told me last week that her job interviews hadn’t gone as well as she’d hoped and her explanation was, “if it isn’t my qualifications, it must be the crow’s feet.”

While she may be exaggerating a bit, she’s not alone in feeling that way; many people are considering the same possibility. When you’re in competition with young adults fresh out of college, who often accept a much lower wage, you need to present yourself in the best possible light.  To get an advantage, many job seekers  turn to their hair stylist for a new look, or their local surgeon for Botox, Dysport, Juvéderm, or even eyelid surgery.

Botox is the most popular non- invasive cosmetic procedure in America.  According to the American Society of Plastic Surgeons, more than 5 million treatments were performed last year. The cost of a single treatment will vary, and it pays to keep an eye out for monthly specials and events.

If you are going for treatments prior to a job interview, give yourself at least 7 days to heal from Botox and other injectables. Remember, doing well on an interview is not only about how you look, but whether you exude confidence about yourself and your ability to do the job.

Ask about our special Botox and Juvéderm rebate programs today!

Survey Analyzes Patients Who Choose Botox, Wrinkle Fillers

Monday, June 1st, 2009

Researchers associated with the American Society for Aesthetic Plastic Surgery (ASAPS) sent questionnaires last March to 687 patients who had received Botox and/or dermal filler treatment. The findings offer some insight about the treatments and the patients who choose them.

The following figures illustrate the opinions of the ‘typical’ patient. Who is the ‘typical’ patient?  According to the survey results, she is “a married, working mother between 41-55 years of age with a household income of under $100,000.”

  • Roughly 70 percent of the respondents claimed that Botox and dermal fillers play an important role in their cosmetic routine. About the same number of respondents who had been treated with Botox also opted for dermal filler treatment.
  • When asked what their motivation was for pursuing Botox treatment, 34 percent said their appearance looked “stressed” or “angry”. Others said that a friend, family member, or their physician had recommended it, or they were preparing for a social event. 66 percent said they received Botox treatment 2-3 times per year. 72 percent of the respondents chose Botox to treat glabellar lines – the vertical lines that appear between your eyebrows.  
  • When asked about their motivation to use hyaluronic acid fillers, the majority (63 percent) of patients reported a desire to remove facial wrinkles and folds – mostly the nasolabial folds that travel from the nose to each side of the mouth.

A full summary of the results is available (in MS Word) here.

Dysport – The New Botox Competitor – Gets FDA Approval

Friday, May 8th, 2009

Dysport, the new wrinkle treatment from Medicis, has received FDA approval for treating wrinkles and dystonia. Plastic surgeons and dermatologists could have the drug available in just 3o days.

Instead of re-branding the drug ‘Reloxin’ as planned, Medicis Pharmaceutical had to retain its original European name.

Along with the April 30th announcement came a 3 percent drop in Allergan’s (maker of Botox) shares, and a 14 percent increase in the shares of Medicis. Analysts and industry professionals expect Medicis to market the drug at a slightly lower price than Botox, and say it could capture as much as 30 percent of the current market.

Botox and Dysport both perform the same basic function – neuromuscular blocking to relax and prevent wrinkles. Dysport however, is said to be more diluted than Botox and thus, more cost effective for providers.

The recent FDA approval of dysport also came with a unique warning label describing the risks associated with the botulinum toxin.

Allergan Announces Latisse Wishes Campaign

Friday, May 8th, 2009

Allergan Inc – the maker of Botox and now, Latisse – sponsored a celebrity charity event last March; Brooke Shields, Mandy Moore, Marisa Tomei, and other Hollywood stars were showed support the new ‘Latisse Wishes’ campaign.

The cause will raise money for the Make-A-Wish foundation and generate interest in Allergan’s new eyelash enhancement drug. A $500,000 initial contribution to Make-A-Wish was announced at the event.

Latisse is the first drug to be approved by the FDA for the treatment of inadequate eyelashes. When applied to the base of the upper eyelids, it stimulates the growth of thicker, darker lashes.

Beauty expert and participant, Anastasia Soare, enthusiastically expressed her support, saying “I constantly work to help make women’s beauty wishes come true, and now we can help children’s wishes come true through the LATISSE™ Wishes campaign.”

It isn’t a mere coincidence that the Make-A-Wish foundation was chosen as a beneficiary; the superstitious tradition of “blowing on an eyelash to make a wish come true” provides a clever marketing strategy.

Allergan is encouraging consumers to help double the donation amount by visiting www.Latisse.com and registering their support. From now until the end of the year, the company will donate 5 dollars for each new registration, up to one million dollars.